Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-24 @ 7:45 PM
NCT ID:
NCT02795403
Eligibility Criteria:
Inclusion Criteria:
* Adult\> 18 and \<60 years
* Infected with HCV genotype 1 HCV antibody positive.
* positive viremia for more than 6 months
* Viremia\> 106 IU / ml.
* nonresponders to previous treatment and without antiviral treatment for 2 months.
* For control samples: Patients responders to previous treatment and without antiviral treatment for 2 months.
Exclusion Criteria:
* Patient receiving or having received antiviral treatment within two months.
* patient with against-indication for a blood sample of 150 ml
* immunosuppressive therapy patient
* Patient with liver disease other than hepatitis C.
* Patients with cirrhosis.
* patient with hepatocellular carcinoma.
* Patients with one or more severe co-morbidities defined as:
* Co-infection with HIV or HBV.
* hematological malignancies changing or aplasia
* Insulin-dependent diabetes
* dialyzed chronic renal failure
* Heart failure
* Persons subject to legal protection or the subject of a safeguard measure of justice not affiliated with a social security scheme or not beneficiaries of such a scheme
* Pregnant women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02795403
Study Brief:
Protocol Section:
NCT02795403